Saad Tabbara, MD
Interventional Cardiology · Pittsburgh, PANPI 1518993542
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) at 47.1% of the total. Reporting peaked in 2023 at $10,589 and has fallen 50.8% since, to $5,209 in 2025.
Across 302 payments — averaging $93.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$13K
- Edwards Lifesciences$3K
- Medtronic$2K
- Penumbra, Inc.$2K
- Teleflex LLC$2K
- Abbott$1K
- plus $5K from 27 others
Across 25 payments — averaging $13,102 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$326K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
What the payments were for
- Consulting fees$1481%
- Speaking & faculty fees$12,00043%
- Grants$550%
- Travel & lodging$3,55813%
- Food & beverage$12,35744%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 68 | $13,233 |
| Edwards Lifesciences | 29 | $3,233 |
| Medtronic(2 entities) | 33 | $1,921 |
| Penumbra, Inc. | 3 | $1,888 |
| Teleflex LLC | 11 | $1,512 |
| Abbott | 20 | $1,067 |
| Boston Scientific | 15 | $940 |
| Abiomed | 6 | $605 |
| Impulse Dynamics (USA) Inc. | 8 | $413 |
| AstraZeneca | 16 | $397 |
| Stryker | 8 | $395 |
| Novartis | 22 | $394 |
| Inari Medical, Inc. | 7 | $279 |
| Johnson & Johnson | 11 | $195 |
| Cardiac Dimensions, Inc. | 1 | $172 |
| Cook Medical LLC | 2 | $166 |
| Jenavalve Technology, Inc. | 1 | $148 |
| W. L. Gore & Associates, Inc. | 1 | $127 |
| Pfizer | 7 | $126 |
| Tactile Systems Technology Inc | 2 | $124 |
| Altathera Pharmaceuticals LLC | 1 | $123 |
| Heartflow, Inc. | 5 | $118 |
| Celonova Biosciences, Inc. | 1 | $89 |
| Amgen | 5 | $85 |
| E.r. Squibb & Sons, L.L.C. | 4 | $79 |
| Angiodynamics, Inc. | 3 | $76 |
| Novo Nordisk | 4 | $65 |
| Boehringer Ingelheim | 3 | $58 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $20 |
| Scpharmaceuticals Inc. | 1 | $18 |
| Lexicon Pharmaceuticals, Inc. | 1 | $16 |
| Cardiva Medical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$12,127
- Indigo System$1,888
- GUIDELINER$1,053
- SAPIEN 3 Ultra RESILIA$804
- CoreValve Evolut$461
- COREVALVE EVOLUT R$432
- Edwards SAPIEN 3 Transcatheter Heart Valve$382
- Impella$379
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$375
- COROFLOW$322
- OPTIMIZER$305
- GENERAL - THERAPIES$169
- VENACORE THROMBECTOMY CATHETER$168
- XACT$162
- Cook Medical Zilver PTX$160
- CARDIOMEMS$155
- OPTICROSS$148
- TURNPIKE$144
- GORE CARDIOFORM Septal Occluder$127
- GENERAL - STRUCTURAL HEART$124
How this compares
$28,118 in reported general payments places this provider in the 80th percentile of 281 interventional cardiology providers in Pennsylvania.
See all interventional cardiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 133 | $113,035 |
| EntrestoSacubitril/Valsartan | 118 | $82,515 |
| XareltoRivaroxaban | 61 | $46,551 |
| JardianceEmpagliflozin | 25 | $18,137 |
| FarxigaDapagliflozin Propanediol | 26 | $16,583 |
| Repatha SureclickEvolocumab | 25 | $13,759 |
| BrilintaTicagrelor | 14 | $7,751 |
| Ranolazine ErRanolazine | 89 | $5,070 |
| Atorvastatin Calcium | 276 | $3,930 |
| Varenicline Tartrate | 13 | $3,891 |
| Icosapent Ethyl | 18 | $3,871 |
| Valsartan | 146 | $3,531 |
| Ezetimibe | 208 | $2,979 |
| Propafenone Hcl ErPropafenone Hcl | 17 | $2,570 |
| Rosuvastatin Calcium | 144 | $2,350 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $126 | $113,035133 claims |
| NovartisEntresto | $394 | $82,515118 claims |
| Johnson & JohnsonXarelto | $195 | $46,55161 claims |
| AstraZenecaFarxiga, Brilinta | $397 | $24,33440 claims |
| Boehringer IngelheimJardiance | $58 | $18,13725 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 281 interventional cardiology providers in Pennsylvania.
Other interventional cardiology in Pittsburgh
- David LasordaPittsburgh$271K
- Ramzi KhalilPittsburgh$217K
- Ryan ZuzekPittsburgh$152K
- Catalin TomaPittsburgh$120K
- Dustin KlinerPittsburgh$73K
- Adnan KhalifPittsburgh$39K
- Jeffrey FowlerPittsburgh$26K
- Marinos CharalambousPittsburgh$25K
- Nishant SethiScranton$1.3M
- Matthew BeckerErie$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.